Alterity Therapeutics (ATHE) Change in Receivables (2015 - 2020)

Alterity Therapeutics has reported Change in Receivables for 6 years, with the latest figure at $898621.0 in Q2 2020.

• For the quarter ending Q2 2020, Change in Receivables rose 176.49% year-over-year to $898621.0; the trailing twelve-month figure through Jun 2020 stood at -$542814.8 (up 15.57% YoY), and the FY2025 full-year result was $66648.6, down 97.81% from the prior year.
• Change in Receivables for Q2 2020 stood at $898621.0, up from -$2.0 million in the prior quarter.
• The five-year high for Change in Receivables was $1.7 million in Q4 2018, with the low at -$2.2 million in Q4 2016.
• Average Change in Receivables over 5 years is -$150911.9, with a median of -$884.5 recorded in 2018.
• Year-over-year, Change in Receivables jumped 243.82% in 2018 and sank 132715.6% in 2019.
• Tracing ATHE's Change in Receivables over 5 years: stood at -$2.2 million in 2016, then jumped by 44.88% to -$1.2 million in 2017, then jumped by 243.82% to $1.7 million in 2018, then plunged by 215.25% to -$2.0 million in 2019, then jumped by 144.59% to $898621.0 in 2020.
• The last three Change in Receivables figures came in at $898621.0 (Q2 2020), -$2.0 million (Q4 2019), and -$1.2 million (Q2 2019), per Business Quant data.

Peer Comparison